The drug failed to slow the progression of early Alzheimer’s. Experts are trying to understand why.
In New Dementia Trials, Ozempic’s ‘Miracle Drug’ Image Takes a Hit
Published 9 hours ago
Source: rss.nytimes.com
Categories
BrainGLP-1 RAs (Drug)Alzheimer's DiseaseResearchOzempic (Drug)DementiaMemoryNovo Nordisk A/S
Related Articles from rss.nytimes.com
10 minutes ago
Trinidad and Tobago Sides With U.S. in Battle Against Venezuela, Military Tool Suggests
16 minutes ago
U.S. Is Seeking Exemption From a European Climate Law, Officials Say
20 minutes ago
Wrong Turns and Long Nights: Inside the Search for the Brown University Attacker
23 minutes ago
Rob and Nick Reiner: A Father-Son Relationship in Several Acts
29 minutes ago
M.I.T. Professor Is Fatally Shot in His Home
35 minutes ago